券商再融资又现"破冰"信号。近日，中泰证券（600918.SH）公告，中国证监会同意公司向特定对象发行股票的注册申请，本批复自同意注册之日起12个月 内有效。 中泰证券表示，公司将按照有关法律法规、批复要求及公司股东会的授权，在规定期限内办理本次向特定对象发行股票的相关事项，并及时履行信息披露义 务。 21世纪经济报道记者注意到，中泰证券60亿元定增申请进展迅速，从受理到批复仅用了约4个半月，这是2025年以来证监会审核的第二家券商再融资项目， 关键节点推进节奏与年内多家券商定增的高效周期一致。 此前9月5日，中泰证券定增获得上交所审核通过；7月14日，中泰证券公告延长60亿元定增计划有效期1年，并在次日答复了监管审核问询函，具体可见21世 纪经济报道此前报道《券商再融资信号！中泰证券60亿定增获准，东吴、南京仍在途》《60亿定增！中泰证券119页公告回复问询函》。 2025年以来，多家券商密集推进定增计划，形成明显的"补血"潮。其中，指南针（300803.SZ）5月更新29亿元定增方案修订稿；天风证券（601162.SH）6月 23日完成40亿元定增募资；东吴证券（601555.SH）7月10日公布60亿元 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 据上交所网站信息，10月13日，中泰证券发布公告，公司于10月13日收到中国证券监督管理委员会出具 的《关于同意中泰证券股份有限公司向特定对象发行股票注册的批复》，同意公司向特定对象发行股票 的注册申请。 公告内容显示，本次发行应严格按照报送上交所的申报文件和发行方案实施，该批复自同意注册之日起 12个月内有效。公司将按照有关法律法规、批复要求及公司股东大会的授权，在规定期限内办理本次向 特定对象发行股票的相关事项，并及时履行信息披露义务。 | 序号 | 募集资金投资项目 | 拟投入金额 | | --- | --- | --- | | 1 | 信息技术及合规风控投入 | 不超过 15 亿元 | | 2 | 另类投资业务 | 不超过 10 亿元 | | 3 | 做市业务 | 不超过 10 亿元 | | 4 | 购买国债、地方政府债、企业债等证券 | 不超过5亿元 | | ર્ | 财富管理业务 | 不超过5亿元 | | e | 偿还债务及补充其他营运资金 | 不超过 15 亿元 | | | 合计 | 不超过 60 亿元 | 中泰证券 公告截图 具体而言，将用于信 ...

（原标题：历时两年，60亿定增终落地！） 【导读】中泰证券定增获批，券商再融资悄然回暖 中国基金报记者 舍梨 耗时两年，中泰证券60亿元定增终于获批。 10月13日，中泰证券公告称，公司向特定对象发行不超过60亿元股票的申请，已获得中国证券监督管理 委员会同意注册批复。 今年以来，券商再融资步伐明显加快。在业内人士看来，随着多家券商相继"补血"，行业整体资本实力 与服务能力有望进一步提升。 中泰证券60亿元定增获批 10月13日晚间，中泰证券公告称，公司于10月13日收到中国证券监督管理委员会出具的《关于同意中泰 证券股份有限公司向特定对象发行股票注册的批复》。批复同意公司向特定对象发行股票，本次发行应 严格按照报送上海证券交易所的申报文件和发行方案实施。 此次定增计划可追溯至两年前。2023年6月30日，中泰证券抛出60亿元定增计划，这也是该公司自2020 年上市以来的首次股权再融资。该议案原定于2024年10月9日到期，但公司决定将其有效期延长12个 月，至2025年10月9日。 进入2025年，这一定增计划的推进节奏明显提速。5月28日，定增申请获上交所受理，9月5日顺利过 会，9月15日提交注册，10 ...

Core Viewpoint - The approval of Zhongtai Securities' 6 billion yuan private placement marks a significant recovery in the securities industry's refinancing activities, indicating an overall improvement in capital strength and service capabilities within the sector [2][7]. Group 1: Company Specifics - Zhongtai Securities received approval from the China Securities Regulatory Commission (CSRC) on October 13 for its plan to issue up to 6 billion yuan in stocks to specific investors [5]. - This private placement plan was initiated two years ago and represents the company's first equity refinancing since its listing in 2020 [5][6]. - The funds raised will be used to enhance capital, with allocations for information technology, compliance risk control, alternative investment, market-making, wealth management, debt repayment, and purchasing various securities [5][6]. Group 2: Industry Context - The securities refinancing market has seen a notable increase in activity this year, with several firms, including Tianfeng Securities and Nanjing Securities, also pursuing significant capital replenishment plans [7][8]. - Regulatory support has encouraged securities firms to supplement their capital through reasonable means, aligning with the goal of better serving the high-quality development of the real economy [7][8]. - The trend in the industry is shifting from mere scale expansion to a focus on quality and efficiency, emphasizing the balance between capital replenishment and business development [8].

【 导读 】中泰证券 定增 获批，券商再融资悄然回暖 中国基金报记者 舍梨 耗时两年，中泰证券60亿元定增终于获批。 10月13日，中泰证券公告称，公司向特定对象发行不超过60亿元股票的申请，已获得中国证券监督管理委员会同意注册批复。 今年以来，券商再融资步伐明显加快。在业内人士看来，随着多家券商相继"补血"，行业整体资本实力与服务能力有望进一步提升。 10月13日晚间，中泰证券公告称，公司于10月13日收到中国证券监督管理委员会出具的《关于同意中泰证券股份有限公司向特定对象发行 股票注册的批复》。批复同意公司向特定对象发行股票，本次发行应严格按照报送上海证券交易所的申报文件和发行方案实施。 此次定增计划可追溯至两年前。2023年6月30日，中泰证券抛出60亿元定增计划，这也是该公司自2020年上市以来的首次股权再融资。该 议案原定于2024年10月9日到期，但公司决定将其有效期延长12个月，至2025年10月9日。 进入2025年，这一定增计划的推进节奏明显提速。5月28日，定增申请获上交所受理，9月5日顺利过会，9月15日提交注册，10月13日最 终获证监会批复。 根据此前中泰证券披露的募集说明书，60亿 ...

Core Viewpoint - Zhongtai Securities has received approval from the China Securities Regulatory Commission (CSRC) for a private placement of 6 billion yuan, marking a significant step in its capital-raising efforts after a prolonged period of inactivity in equity financing [1][8]. Summary by Sections Approval and Issuance - On October 13, Zhongtai Securities announced that it received the CSRC's approval for a stock issuance to specific investors, which must be executed according to the submitted documents and issuance plan [1]. - The approval is valid for 12 months from the date of registration [1]. Fundraising Details - The private placement will raise up to 6 billion yuan, with the number of shares issued not exceeding 30% of the company's total share capital prior to the issuance, equating to a maximum of 2.091 billion shares [3]. - The controlling shareholder, Zao Mining Group, is set to subscribe for 36.09% of the new shares, amounting to no more than 2.166 billion yuan [3]. Use of Proceeds - The funds raised will be allocated to six key areas, including: 1. Information technology and compliance risk control: up to 1.5 billion yuan 2. Alternative investment business: up to 1 billion yuan 3. Market-making business: up to 1 billion yuan 4. Purchase of government bonds and corporate bonds: up to 500 million yuan 5. Wealth management business: up to 500 million yuan 6. Debt repayment and operational capital: up to 1.5 billion yuan [4]. Historical Context - The plan for this private placement was initiated over two years ago, with the first proposal made on June 30, 2023, marking the company's first equity financing since its listing in 2020 [6]. - The proposal's validity was extended multiple times, with the latest extension allowing it to remain effective until July 14, 2026 [6][7]. Market Position and Strategy - Zhongtai Securities has not engaged in equity refinancing since its listing, relying instead on non-equity financing methods, which has led to a relatively high debt level and insufficient net capital replenishment [7]. - The company views this fundraising as a necessary step to align with regulatory support for capital replenishment and to enhance its service capabilities for the real economy [6][7].

来源|中访网 中泰证券此次定增的落地，并非个例，而是今年券业再融资"回暖"的缩影。此前一年多时间里，券商再 融资市场相对沉寂，但2024年以来，多家券商密集推进资本补充计划，形成明显的"补血"潮。6月23 日，天风证券顺利完成40亿元定增募资，为业务扩张提供资金支撑；9月29日，南京证券50亿元定增计 划获上交所审核通过，进入后续实施阶段；7月，东吴证券也公布60亿元定增预案，拟通过资本补充增 强综合竞争力。 从行业背景来看，券商密集"补血"既是自身发展需求，也顺应了监管导向与市场趋势。近年来，随着资 本市场改革深化，券商在财富管理、投资银行、资产管理等业务领域的竞争日趋激烈，而这些业务的开 展均需充足的资本金作为支撑。与此同时，监管层也持续支持证券公司通过合理方式补充资本，鼓励券 商更好地服务实体经济高质量发展。 对于中泰证券而言，此次定增的意义尤为特殊。据公司此前披露，上市后其主要依赖非股权方式融资， 导致负债规模相对较高，净资本补充受限，已形成一定的资本缺口。此次60亿元定增的落地，将有效缓 解这一问题——不仅能提升净资本规模，优化资本结构，还能为业务拓展提供充足资金，助力公司在券 业竞争中抢占更有利地 ...

点评：中泰证券60亿元定增获批，标志着券商行业"补血"进程加速。此举将显著提升其资本实力，为业 务扩张提供支撑，市场对其估值预期或重新评估。行业层面，多家券商再融资动作频频，显示板块整体 资本补充需求旺盛，头部效应或将强化。对股市而言，券商作为市场重要参与者，资本金增强有助于提 升市场活跃度，但短期内需关注资金分流效应及板块内部竞争格局变化。 NO.2国投证券董事长王苏望辞任总经理，廖笑非接棒 10月13日，国投证券发布公告称，公司董事长王苏望因职务调整辞任总经理，仅保留董事长及董事会专 业委员会相应职务。与此同时，公司正式聘任廖笑非为新任总经理，且国投证券官网已同步更新该信 息。作为深耕证券行业多年的"老兵"，廖笑非履历覆盖券商业务、监管及合规等多领域。回溯国投证券 近年发展，自2023年净利润跌至行业第26位后，管理层开启"大换血"，从王苏望代行总经理，到逐步完 成高管团队搭建。公司2024年业绩触底反弹，净利润同比增30.49%且行业排名上升9位，2025年上半年 净利润同比增长44.83%。如今廖笑非上任，能否延续公司业绩增长态势，接好这根关键的"接力棒"，成 为市场关注的焦点。 NO.3锦龙股份30 ...

Core Viewpoint - Zhongtai Securities has received approval from the China Securities Regulatory Commission (CSRC) for a private placement of shares amounting to 6 billion yuan, marking a significant step in its capital-raising efforts after a prolonged period of inactivity in equity financing [1][5]. Group 1: Fundraising Details - The company plans to issue up to 2.091 billion shares, which is no more than 30% of its total share capital prior to the issuance [2]. - The controlling shareholder, Zhaomining Group, is set to subscribe for 36.09% of the new shares, amounting to a maximum of 2.166 billion yuan [2]. - The total funds raised will be used to enhance the company's capital base, optimize its business structure, and improve market competitiveness and risk resilience [2][4]. Group 2: Historical Context - The fundraising initiative was first proposed over two years ago, with the initial plan announced on June 30, 2023, marking the company's first equity financing since its listing in 2020 [3]. - The approval process involved multiple extensions and responses to regulatory inquiries, reflecting the complexities of the approval process [3][5]. - The company has not engaged in equity refinancing since its listing, relying instead on non-equity financing methods, which has led to a relatively high debt level and insufficient net capital replenishment [4]. Group 3: Regulatory Approval Process - The CSRC's approval is valid for 12 months from the date of issuance, allowing the company to proceed with the share issuance within this timeframe [1]. - The Shanghai Stock Exchange had previously indicated that the company's application met the necessary conditions for issuance and listing [5].

Group 1 - Guolian Minsheng Securities' Hong Kong subsidiary has obtained a trading license from the SFC, enhancing its capabilities in investment banking, trading, and custody services [1] - The Hong Kong securities market has seen a significant increase in trading activity, with net profits in the first half of the year rising by 14%, driven by a surge in trading volumes [1] - The growth in trading commission income and investment banking revenue, which increased by 23% and 33% respectively, indicates a robust market environment for securities firms [1] Group 2 - Nanjing Securities' 50 billion yuan private placement plan has been approved by the Shanghai Stock Exchange, signaling a recovery in the securities refinancing market [2] - This marks the third securities firm to receive approval for a private placement this year, indicating a trend of increasing capital replenishment among brokerages [2] - The approval is expected to enhance Nanjing Securities' risk resilience and business expansion capabilities, potentially reshaping market valuation expectations [2] Group 3 - A total of 68 new funds are set to launch starting October 9, with 23 funds debuting on the first day, reflecting increased institutional confidence in the market [3] - The surge in fund issuance is likely to inject new capital into the market, particularly benefiting growth sectors such as technology and consumer goods [3] - The concentration of new fund launches may boost market sentiment, although attention should be paid to capital flow and market absorption capacity [3] Group 4 - Guosheng Financial announced that its stock price has experienced significant fluctuations, but the company confirmed that there are no undisclosed major issues affecting its operations [4] - The announcement aims to clarify the company's stable operational status amidst market speculation regarding its stock price movements [4] - The financial sector is currently experiencing volatility influenced by policy expectations, which may lead to increased differentiation among individual stocks [4]